Jim Wassil - 15 Feb 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF OPERATING OFFICER
Signature
Jim Wassil, by /s/ Andrew Guggenhime, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
15 Feb 2024
Transactions value $
$67,559
Form type
4
Date filed
20 Feb 2024, 16:22
Previous filing
05 Feb 2024
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $67.6K +27.9K +15.87% $2.42* 204K 15 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -27.9K -30.83% $0.00 62.6K 15 Feb 2024 Common Stock 27.9K $2.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.